NasdaqGS:TWSTBiotechs
Twist Bioscience (TWST) Q1 Loss After One Off Profit Tests Bullish Profitability Narrative
Twist Bioscience (TWST) opened Q1 2026 with revenue of US$103.7 million and a basic EPS loss of US$0.50, while net income excluding extra items came in at a loss of US$30.5 million. The company reported revenue of US$84.7 million in Q4 2024, US$88.7 million in Q1 2025 and US$103.7 million in Q1 2026. Quarterly basic EPS ranged from a loss of US$0.59 in Q4 2024 to a profit of US$0.34 in Q3 2025 before returning to a loss of US$0.50 in the latest quarter. This keeps the focus on how efficiently...